Compare

Aptevo Therapeutics Inc. vs TuHURA Biosciences, Inc. vs Skye Bioscience, Inc. vs BeyondSpring Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Aptevo Therapeutics Inc. APVORevenue covers only part of its income (partial revenue)	TuHURA Biosciences, Inc. HURA	Skye Bioscience, Inc. SKYE	BeyondSpring Inc. BYSI
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	$0	n/a	$0
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$25.97M	-$30.05M	-$55.92M	-$1.01M
EPS (Diluted)	-$87.27	-$0.63	-$1.41	n/a
Operating cash flow	-$25.59M	-$27.63M	-$43.06M	-$19.77M
Free cash flow	n/a	-$27.71M	-$43.07M	-$19.82M
Cash & equivalents	$21.62M	$3.62M	$5.88M	$7.79M
Total assets	$27.19M	$27.35M	$28.31M	$25.93M
Total liabilities	$9.81M	$6.42M	$8.29M	$49.92M
Shareholders' equity	$17.38M	$20.93M	$20.02M	-$23.99M
Return on year-end equity	-149.4%	-143.6%	-279.3%	n/a
Shares outstanding	997.8K	59.34M	33.38M	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Aptevo Therapeutics Inc.	TuHURA Biosciences, Inc.	Skye Bioscience, Inc.	BeyondSpring Inc.
Latest	n/a	$0 Ended 2025-12-31	n/a	$0 Ended 2025-12-31
1 year earlier	n/a	$0 Ended 2024-12-31	n/a	$0 Ended 2024-12-31
2 years earlier	n/a	$0 Ended 2023-12-31	n/a	$0 Ended 2023-12-31
3 years earlier	n/a	n/a	n/a	$1.35M Ended 2022-12-31
4 years earlier	n/a	n/a	n/a	$1.35M Ended 2021-12-31